EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

A Novel Tetramethylpyrazine Chalcone Hybrid- HCTMPPK, as a Potential Anti-Lung Cancer Agent by Downregulating MELK

Yan Ma, Qian Cui, Wenjing Zhu, Mei Wang, Li Zhai, Wenmin Hu, Dongdong Liu, Min Liu, Yongchun Li, Meng Li, Wei Han

Drug Design, Development and Therapy · 2024

DOI: 10.2147/dddt.s449139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Yan Ma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Qingdao Key Laboratory of Common Diseases, Qingdao Municipal Hospital, School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong,…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Chalcone, Down-Regulation, Lung Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsChalconeDown-RegulationLung NeoplasmsPyrazinesAnimalsHumansMiceA549 CellsApoptosisCell MovementCell ProliferationDose-Response Relationship, DrugDrug Screening Assays, AntitumorMice, Inbred BALB CMice, NudeMolecular Docking SimulationMolecular StructureNeoplasms, ExperimentalStructure-Activity RelationshipTumor Cells, Cultured

Stichwörter der Autor:innen

AutoDockHCTMPPK((E) -1- (E) -1- (2-hydroxy-5-chlorophenyl) -3- (3,5,6-trimethylpyrazin-…TMPchalconelung adenocarcinomanetwork pharmacology

Substanzen

Antineoplastic AgentsChalconePyrazinestetramethylpyrazine

Autor:innen und Institutionen

  • Qingdao Key Laboratory of Common Diseases, Qingdao Municipal Hospital, School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong, 260071, People's Republic of China.
  • Department of Respiratory and Critical Care Medicine, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, 266071, People's Republic of China.
  • Department of Respiratory and Critical Care Medicine, Shenzhen Luohu People's Hospital, Shenzhen, 518000, People's Republic of China.
  • NMPA Key Laboratory for Quality Research and Evaluation of Traditional Marine Chinese Medicine, Qingdao, 266071, People's Republic of China.
  • Department of Pharmacy, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, 266071, People's Republic of China.
  • Department of Respiratory and Critical Care Medicine, Shanting District People's Hospital, Zaozhuang, 277200, People's Republic of China.

Zitieren

APA

Ma, Y., Cui, Q., Zhu, W., Wang, M., Zhai, L., Hu, W., Liu, D., Liu, M., Li, Y., Li, M., & Han, W. (2024). A Novel Tetramethylpyrazine Chalcone Hybrid- HCTMPPK, as a Potential Anti-Lung Cancer Agent by Downregulating MELK. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s449139

Vancouver

Ma Y, Cui Q, Zhu W, Wang M, Zhai L, Hu W, et al. A Novel Tetramethylpyrazine Chalcone Hybrid- HCTMPPK, as a Potential Anti-Lung Cancer Agent by Downregulating MELK. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s449139

BibTeX
@article{Ma2024,
  author = {Ma, Yan and Cui, Qian and Zhu, Wenjing and Wang, Mei and Zhai, Li and Hu, Wenmin and Liu, Dongdong and Liu, Min and Li, Yongchun and Li, Meng and Han, Wei},
  title = {A Novel Tetramethylpyrazine Chalcone Hybrid- HCTMPPK, as a Potential Anti-Lung Cancer Agent by Downregulating MELK},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  doi = {10.2147/dddt.s449139}
}
Kostenlos starten →